Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Net Income (2016 - 2025)

Biomerica's Net Income history spans 16 years, with the latest figure at -$1.3 million for Q4 2025.

  • For Q4 2025, Net Income fell 38.84% year-over-year to -$1.3 million; the TTM value through Nov 2025 reached -$4.0 million, up 28.22%, while the annual FY2025 figure was -$5.0 million, 16.81% up from the prior year.
  • Net Income for Q4 2025 was -$1.3 million at Biomerica, down from $2000.0 in the prior quarter.
  • Across five years, Net Income topped out at $2000.0 in Q3 2025 and bottomed at -$6.7 million in Q2 2021.
  • The 5-year median for Net Income is -$1.5 million (2021), against an average of -$1.6 million.
  • The largest annual shift saw Net Income plummeted 1483.98% in 2023 before it surged 100.15% in 2025.
  • A 5-year view of Net Income shows it stood at -$1.1 million in 2021, then tumbled by 44.52% to -$1.6 million in 2022, then rose by 7.33% to -$1.5 million in 2023, then soared by 36.96% to -$950000.0 in 2024, then plummeted by 38.84% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Net Income are -$1.3 million (Q4 2025), $2000.0 (Q3 2025), and -$1.5 million (Q2 2025).